Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adiponectin acts as an endogenous antithrombotic factor.

Hisashi Kato1, Hirokazu Kashiwagi, Masamichi Shiraga

  • 1Department of Hematology and Oncology, Graduate School of Medicine, Osaka University, Suita, Japan.

Arteriosclerosis, Thrombosis, and Vascular Biology
|November 5, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Current diagnosis and treatment of congenital platelet function disorders: focus on Glanzmann thrombasthenia and Bernard-Soulier syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same author

TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial.

International journal of hematology·2026
Same author

Simultaneous Pancreas and Kidney Transplantation in a Patient With Congenital Hemophilia A: A rare Case Report and Management Insights.

Transplantation proceedings·2026
Same author

A small proportion of CD8 T cells expand robustly when stimulated with BCMAxCD3 bispecific T-cell engagers in vitro.

Leukemia·2026
Same author

Complement activation profile in adult primary immune thrombocytopenia.

Blood·2026
Same author

Successful treatment of refractory DLBCL coexisting with SLE using Liso-cel, complicated by cytokine release syndrome.

Rheumatology (Oxford, England)·2025

Adiponectin deficiency accelerates blood clot formation and platelet aggregation. This study identifies adiponectin as a crucial endogenous antithrombotic factor, impacting cardiovascular health.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Metabolic Diseases

Background:

  • Obesity is linked to insulin resistance and cardiovascular issues.
  • Hypoadiponectinemia is associated with metabolic and vascular diseases.
  • Adiponectin's role in thrombosis is not well understood.

Purpose of the Study:

  • To investigate the role of adiponectin in platelet thrombus formation.
  • To determine if adiponectin acts as an antithrombotic factor.

Main Methods:

  • Studied adiponectin knockout (APN-KO) mice and wild-type (WT) littermates.
  • Assessed platelet thrombus formation in vivo using carotid arterial injury.
  • Evaluated in vitro thrombus formation on collagen and platelet aggregation.
  • Utilized adenovirus-mediated gene transfer for adiponectin supplementation/overexpression.

Related Experiment Videos

Main Results:

  • APN-KO mice exhibited significantly accelerated thrombus formation compared to WT mice.
  • Platelet aggregation was enhanced in APN-KO mice and inhibited by adiponectin.
  • Adiponectin supplementation or overexpression attenuated thrombus formation in both APN-KO and WT mice.

Conclusions:

  • Adiponectin deficiency enhances thrombus formation and platelet aggregation.
  • Adiponectin functions as an endogenous antithrombotic factor.
  • This finding reveals a novel protective role for adiponectin in preventing thrombosis.